SA.”Type: Oral PresentationTitle: Topline Data from a Randomized, Double Blind, Placebo Controlled Phase 2Study of ATH434 in Multiple System AtrophyPresenter: Daniel Claassen, M.D., M.S., Professor of Neurology at Vanderbilt UniversityMedical CenterDate/Time: Wednesday, April 9, 2025 at 2:24 PM PDT (USA)Type:
Poster PresentationTitle: Association Between Wearable Sensor Data and Clinical Scores in Individualswith Early-stage Multiple System AtrophyPresenter: Date/Time: Ashkan Vaziri, PhD, BioSensics LLCSaturday, April 5, 2025 at 11:45 AM PDT (USA)
i’m glad that Professor Daniel Claassen is presenting..
SA.”Type: Oral PresentationTitle: Topline Data from a...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 1.0¢ | $60.81K | 5.737M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 16255465 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 1643984 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |